tirzepatide cardiovascular outcomes trial results july 2025 event risk assessment: a pre-specified meta-analysis A 72-week trial compared the

We recommend using your abdomen first, but if you find it difficult to inject here or cannot see what youre doing, try your upper legs

Patients should use non-oral contraceptives or a backup method for 4 weeks after initiation and after each dose escalation

Both groups show equivalent weight loss and metabolic outcomes when adherence is controlled for

Glycaemic control studies glucose-tolerance testing, HOMA-IR equivalents, and -cell function markers in diet-induced obese models

Postgraduate Medicine, 134 (1), 1419

Why Weight Plateaus Are Common and Expected Despite the effectiveness of tirzepatide, nearly everyone eventually reached a point where they stopped losing additional weighta common occurrence known as a weight plateau